Urology Clinical Update: ​Comparing Newly Approved Therapies for Non-Muscle-Invasive Bladder Cancer

Activity Description

Urology Clinical Update: Comparing Newly Approved Therapies for NMIBC will focus on how novel agents have reshaped bladder-sparing options for non-muscle invasive bladder cancer (NMIBC) since 2022. This session gives health care providers a working comparison of each agent’s mechanism, NCCN-guided place in therapy, administration and toxicity profile, and the cost/drug-accrual logistics that determine how patients access them in practice.

CE Credit: 0.5 hours
Fee: This activity does not require payment to register.

ACCESS CE ACTIVITY

Learning Objectives

1. Compare the clinical characteristics of various agents used in the NMIBC setting, including their mechanisms of action, indications, guideline placement, administration, and safety profiles.​
2. Explain pharmacy operational considerations associated with various agents used in the NMIBC setting, including hazardous-drug handling, coding, buy-and-bill processes, and patient access.​

Obtaining CE Credit

To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:

• Reviewing the course learning materials.
• Confirming information provided on registration.
• Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
• Submitting the CE Code (disclosed towards the end of all CE activities)
• Completing all listed evaluations and CE assessments.  

Credit requirements must be completed before the date of the activity. Upon completion, eligible continuing education credit will be submitted to the appropriate accrediting body. Pharmacist and pharmacy technician credit will be reported to ACPE and reflected in your CPE Monitor profile within 24 hours. Reporting timelines for other healthcare professions may vary by accrediting body or state board.